These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells. Suzuki Y; Mogami H; Ihara H; Urano T Blood; 2009 Jan; 113(2):470-8. PubMed ID: 18922856 [TBL] [Abstract][Full Text] [Related]
5. The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Jiang Q; Gingles NA; Olivier MA; Miles LA; Parmer RJ Blood; 2011 Jun; 117(26):7155-63. PubMed ID: 21596853 [TBL] [Abstract][Full Text] [Related]
6. Protein mobility within secretory granules. Weiss AN; Bittner MA; Holz RW; Axelrod D Biophys J; 2014 Jul; 107(1):16-25. PubMed ID: 24988337 [TBL] [Abstract][Full Text] [Related]
7. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258 [TBL] [Abstract][Full Text] [Related]
8. Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion. Abbineni PS; Bohannon KP; Bittner MA; Axelrod D; Holz RW Neurosci Lett; 2019 Apr; 699():134-139. PubMed ID: 30711526 [TBL] [Abstract][Full Text] [Related]
9. Integrating Optical and Electrochemical Approaches to Assess the Actions of Dynamin at the Fusion Pore. Smith KA; Prantzalos ER; Anantharam A Methods Mol Biol; 2020; 2159():163-178. PubMed ID: 32529370 [TBL] [Abstract][Full Text] [Related]
10. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand. Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673 [TBL] [Abstract][Full Text] [Related]
11. A new role for the dynamin GTPase in the regulation of fusion pore expansion. Anantharam A; Bittner MA; Aikman RL; Stuenkel EL; Schmid SL; Axelrod D; Holz RW Mol Biol Cell; 2011 Jun; 22(11):1907-18. PubMed ID: 21460182 [TBL] [Abstract][Full Text] [Related]
12. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954 [TBL] [Abstract][Full Text] [Related]
13. Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA. Urano T; Suzuki Y J Biomed Biotechnol; 2012; 2012():208108. PubMed ID: 23118500 [TBL] [Abstract][Full Text] [Related]
14. Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment. Maynadier M; Farnoud R; Lamy PJ; Laurent-Matha V; Garcia M; Rochefort H Int J Oncol; 2013 Nov; 43(5):1683-90. PubMed ID: 24026424 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography. Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667 [TBL] [Abstract][Full Text] [Related]